Medtronic plc (MDT) operating KPIs
MDTNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends April 24
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 3, 2026Score 19/303% below fair value
$96.54−0.57 (-0.59%)
Close on Oct 30, 2026Market cap $123.49BP/E 23.7Yield 2.94%
Medtronic non-GAAP R&D Expense ($M) ($M)
Annual figures from Medtronic's filings and investor materials
Latest, FY2026
2,872
Period ended Apr 30, 2026
Change on a year earlier
+5.6%
2,719 in FY2025
History
9 years
Since FY2018
Sources
9
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Non-GAAP R&D Expense ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2026 | Apr 30, 2026 | 2,872 | +5.6% | Medtronic SEC 8K_EARNINGS — FY2026Q4 (filed 2026-06-03) ↗ |
| FY2025 | Apr 30, 2025 | 2,719 | +0.8% | Medtronic SEC 8K_EARNINGS — FY2025Q4 (filed 2025-05-21) ↗ |
| FY2024 | Apr 30, 2024 | 2,698 | +2.5% | Medtronic SEC 8K_EARNINGS — FY2024Q4 (filed 2024-05-23) ↗ |
| FY2023 | Apr 30, 2023 | 2,632 | -2.6% | Medtronic SEC 8K_EARNINGS — FY2023Q4 (filed 2023-05-25) ↗ |
| FY2022 | Apr 30, 2022 | 2,701 | +9.9% | Medtronic SEC 8K_EARNINGS — FY2022Q4 (filed 2022-05-26) ↗ |
| FY2021 | Apr 30, 2021 | 2,458 | +6.7% | Medtronic SEC 8K_EARNINGS — FY2021Q4 (filed 2021-05-27) ↗ |
| FY2020 | Apr 30, 2020 | 2,303 | -1.2% | Medtronic SEC 8K_EARNINGS — FY2020Q4 (filed 2020-05-21) ↗ |
| FY2019 | Apr 30, 2019 | 2,330 | +3.4% | Medtronic SEC 8K_EARNINGS — FY2019Q4 (filed 2019-05-23) ↗ |
| FY2018 | Apr 30, 2018 | 2,253 | – | Medtronic SEC 8K_EARNINGS — FY2018Q4 (filed 2018-05-24) ↗ |
Cite this data
StockData. (2026). Medtronic Non-GAAP R&D Expense ($M) ($M), annual FY2018–FY2026 [Data set]. Compiled from Medtronic SEC filings and investor materials. https://stockdatahq.com/stocks/mdt/kpis/ng-rd-exp
See every metric in the Medtronic KPI table. Data updated Oct 31, 2026.